Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2025-12-26 @ 2:42 PM
NCT ID: NCT01564706
Description: None
Frequency Threshold: 0
Time Frame: AEs occuring within 3 days of injection; SAEs occuring within 30 days of injection
Study: NCT01564706
Study Brief: A Study of 18F-AV-45 in Healthy Volunteers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Healthy Volunteers Single i.v. administration of approximately 10mCi 18F-AV-45 None None 0 9 5 9 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
PALPITATIONS SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (10.0) View
NAUSEA SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
CHEST PAIN SYSTEMATIC_ASSESSMENT General disorders MedDRA (10.0) View
BACK PAIN SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (10.0) View
MUSCULOSKELETAL PAIN SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (10.0) View
ANXIETY SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (10.0) View